- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Gene Editing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gene Editing market size will reach USD 5301 million in 2028, growing at a CAGR of 7.6% over the analysis period
Global key companies of Gene Editing include Thermo Fisher Scientific, Merck, Horizon Discovery, Sangamo BioSciences, and Integrated DNA Technologies, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gene Editing market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Market segment by Application, can be divided into
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Market segment by players, this report covers
Thermo Fisher Scientific
Merck
Horizon Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Gene Editing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Editing, with recent developments and future plans
Chapter 3, the Gene Editing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Gene Editing market forecast, by regions, with revenue, from 2022 to 2028.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.
Chapter 7 and 8, to describe Gene Editing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Gene Editing
1.2 Classification of Gene Editing by Type
1.2.1 Overview: Global Gene Editing Market Size by Type: 2022 Versus 2028
1.2.2 Global Gene Editing Revenue Market Share by Type in 2028
1.2.3 Zinc finger nucleases (ZFNs)
1.2.4 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.5 CRISPR-Cas system
1.3 Global Gene Editing Market by Application
1.3.1 Overview: Global Gene Editing Market Size by Application: 2022 Versus 2028
1.3.2 Biotechnology & Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Global Gene Editing Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Gene Editing Market Drivers
1.5.2 Gene Editing Market Restraints
1.5.3 Gene Editing Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Gene Editing Product and Solutions
2.1.4 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Gene Editing Product and Solutions
2.2.4 Merck Recent Developments and Future Plans
2.3 Horizon Discovery
2.3.1 Horizon Discovery Details
2.3.2 Horizon Discovery Major Business
2.3.3 Horizon Discovery Gene Editing Product and Solutions
2.3.4 Horizon Discovery Recent Developments and Future Plans
2.4 Sangamo BioSciences
2.4.1 Sangamo BioSciences Details
2.4.2 Sangamo BioSciences Major Business
2.4.3 Sangamo BioSciences Gene Editing Product and Solutions
2.4.4 Sangamo BioSciences Recent Developments and Future Plans
2.5 Integrated DNA Technologies
2.5.1 Integrated DNA Technologies Details
2.5.2 Integrated DNA Technologies Major Business
2.5.3 Integrated DNA Technologies Gene Editing Product and Solutions
2.5.4 Integrated DNA Technologies Recent Developments and Future Plans
2.6 Lonza
2.6.1 Lonza Details
2.6.2 Lonza Major Business
2.6.3 Lonza Gene Editing Product and Solutions
2.6.4 Lonza Recent Developments and Future Plans
2.7 New England Biolabs
2.7.1 New England Biolabs Details
2.7.2 New England Biolabs Major Business
2.7.3 New England Biolabs Gene Editing Product and Solutions
2.7.4 New England Biolabs Recent Developments and Future Plans
2.8 OriGene Technologies
2.8.1 OriGene Technologies Details
2.8.2 OriGene Technologies Major Business
2.8.3 OriGene Technologies Gene Editing Product and Solutions
2.8.4 OriGene Technologies Recent Developments and Future Plans
2.9 Transposagen Biopharmaceuticals
2.9.1 Transposagen Biopharmaceuticals Details
2.9.2 Transposagen Biopharmaceuticals Major Business
2.9.3 Transposagen Biopharmaceuticals Gene Editing Product and Solutions
2.9.4 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.10 Editas Medicine
2.10.1 Editas Medicine Details
2.10.2 Editas Medicine Major Business
2.10.3 Editas Medicine Gene Editing Product and Solutions
2.10.4 Editas Medicine Recent Developments and Future Plans
2.11 CRISPR Therapeutics
2.11.1 CRISPR Therapeutics Details
2.11.2 CRISPR Therapeutics Major Business
2.11.3 CRISPR Therapeutics Gene Editing Product and Solutions
2.11.4 CRISPR Therapeutics Recent Developments and Future Plans
2.12 RGen Solutions
2.12.1 RGen Solutions Details
2.12.2 RGen Solutions Major Business
2.12.3 RGen Solutions Gene Editing Product and Solutions
2.12.4 RGen Solutions Recent Developments and Future Plans
2.13 Sigma-Aldrich
2.13.1 Sigma-Aldrich Details
2.13.2 Sigma-Aldrich Major Business
2.13.3 Sigma-Aldrich Gene Editing Product and Solutions
2.13.4 Sigma-Aldrich Recent Developments and Future Plans
2.14 GeneCopoeia
2.14.1 GeneCopoeia Details
2.14.2 GeneCopoeia Major Business
2.14.3 GeneCopoeia Gene Editing Product and Solutions
2.14.4 GeneCopoeia Recent Developments and Future Plans
2.15 Genscript Biotech
2.15.1 Genscript Biotech Details
2.15.2 Genscript Biotech Major Business
2.15.3 Genscript Biotech Gene Editing Product and Solutions
2.15.4 Genscript Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Editing Revenue and Share by Players (2022 & 2028)
3.2 Gene Editing Players Head Office, Products and Services Provided
3.3 Gene Editing Mergers & Acquisitions
3.4 Gene Editing New Entrants and Expansion Plans
4 Global Gene Editing Forecast by Region
4.1 Global Gene Editing Market Size by Region: 2022 VS 2028
4.2 Global Gene Editing Market Size by Region, (2022-2028)
4.3 North America
4.3.1 Key Companies of Gene Editing in North America
4.3.2 Current Situation and Forecast of Gene Editing in North America
4.3.3 North America Gene Editing Market Size and Prospect (2022-2028)
4.4 Europe
4.4.1 Key Companies of Gene Editing in Europe
4.4.2 Current Situation and Forecast of Gene Editing in Europe
4.4.3 Europe Gene Editing Market Size and Prospect (2022-2028)
4.5 Asia-Pacific
4.5.1 Key Companies of Gene Editing in Asia-Pacific
4.5.2 Current Situation and Forecast of Gene Editing in Asia-Pacific
4.5.3 Asia-Pacific Gene Editing Market Size and Prospect (2022-2028)
4.6 South America
4.6.1 Key Companies of Gene Editing in South America
4.6.2 Current Situation and Forecast of Gene Editing in South America
4.6.3 South America Gene Editing Market Size and Prospect (2022-2028)
4.7 Middle East & Africa
4.7.1 Key Companies of Gene Editing in Middle East & Africa
4.7.2 Current Situation and Forecast of Gene Editing in Middle East & Africa
4.7.3 Middle East & Africa Gene Editing Market Size and Prospect (2022-2028)
5 Market Size Segment by Type
5.1 Global Gene Editing Market Forecast by Type (2022-2028)
5.2 Global Gene Editing Market Share Forecast by Type (2022-2028)
6 Market Size Segment by Application
6.1 Global Gene Editing Market Forecast by Application (2022-2028)
6.2 Global Gene Editing Market Share Forecast by Application (2022-2028)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
List of Tables
Table 1. Global Gene Editing Revenue by Type, (USD Million), 2022 VS 2028
Table 2. Global Gene Editing Revenue by Application, (USD Million), 2022 VS 2028
Table 3. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific Gene Editing Product and Solutions
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Gene Editing Product and Solutions
Table 9. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 10. Horizon Discovery Major Business
Table 11. Horizon Discovery Gene Editing Product and Solutions
Table 12. Sangamo BioSciences Corporate Information, Head Office, and Major Competitors
Table 13. Sangamo BioSciences Major Business
Table 14. Sangamo BioSciences Gene Editing Product and Solutions
Table 15. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 16. Integrated DNA Technologies Major Business
Table 17. Integrated DNA Technologies Gene Editing Product and Solutions
Table 18. Lonza Corporate Information, Head Office, and Major Competitors
Table 19. Lonza Major Business
Table 20. Lonza Gene Editing Product and Solutions
Table 21. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 22. New England Biolabs Major Business
Table 23. New England Biolabs Gene Editing Product and Solutions
Table 24. OriGene Technologies Corporate Information, Head Office, and Major Competitors
Table 25. OriGene Technologies Major Business
Table 26. OriGene Technologies Gene Editing Product and Solutions
Table 27. Transposagen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 28. Transposagen Biopharmaceuticals Major Business
Table 29. Transposagen Biopharmaceuticals Gene Editing Product and Solutions
Table 30. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 31. Editas Medicine Major Business
Table 32. Editas Medicine Gene Editing Product and Solutions
Table 33. CRISPR Therapeutics Corporate Information, Head Office, and Major Competitors
Table 34. CRISPR Therapeutics Major Business
Table 35. CRISPR Therapeutics Gene Editing Product and Solutions
Table 36. RGen Solutions Corporate Information, Head Office, and Major Competitors
Table 37. RGen Solutions Major Business
Table 38. RGen Solutions Gene Editing Product and Solutions
Table 39. Sigma-Aldrich Corporate Information, Head Office, and Major Competitors
Table 40. Sigma-Aldrich Major Business
Table 41. Sigma-Aldrich Gene Editing Product and Solutions
Table 42. GeneCopoeia Corporate Information, Head Office, and Major Competitors
Table 43. GeneCopoeia Major Business
Table 44. GeneCopoeia Gene Editing Product and Solutions
Table 45. Genscript Biotech Corporate Information, Head Office, and Major Competitors
Table 46. Genscript Biotech Major Business
Table 47. Genscript Biotech Gene Editing Product and Solutions
Table 48. Global Gene Editing Revenue (USD Million) by Players (2022 & 2028)
Table 49. Global Gene Editing Revenue Share by Players (2022 & 2028)
Table 50. Gene Editing Players Head Office, Products and Services Provided
Table 51. Gene Editing Mergers & Acquisitions in the Past Five Years
Table 52. Gene Editing New Entrants and Expansion Plans
Table 53. Global Market Gene Editing Revenue (USD Million) Comparison by Region (2022 VS 2028)
Table 54. Global Gene Editing Revenue Market Share by Region (2022-2028)
Table 55. Key Companies of Gene Editing in North America
Table 56. Current Situation and Forecast of Gene Editing in North America
Table 57. Key Companies of Gene Editing in Europe
Table 58. Current Situation and Forecast of Gene Editing in Europe
Table 59. Key Companies of Gene Editing in Asia-Pacific
Table 60. Current Situation and Forecast of Gene Editing in Asia-Pacific
Table 61. Key Companies of Gene Editing in China
Table 62. Key Companies of Gene Editing in Japan
Table 63. Key Companies of Gene Editing in South Korea
Table 64. Key Companies of Gene Editing in South America
Table 65. Current Situation and Forecast of Gene Editing in South America
Table 66. Key Companies of Gene Editing in Middle East & Africa
Table 67. Current Situation and Forecast of Gene Editing in Middle East & Africa
Table 68. Global Gene Editing Revenue Forecast by Type (2022-2028)
Table 69. Global Gene Editing Revenue Forecast by Application (2022-2028)
List of Figures
Figure 1. Gene Editing Picture
Figure 2. Global Gene Editing Revenue Market Share by Type in 2028
Figure 3. Zinc finger nucleases (ZFNs)
Figure 4. Transcription Activator-Like Effector-based Nucleases (TALENs)
Figure 5. CRISPR-Cas system
Figure 6. Gene Editing Revenue Market Share by Application in 2028
Figure 7. Biotechnology & Pharmaceutical Companies Picture
Figure 8. Academic & Government Research Institutes Picture
Figure 9. Contract Research Organizations Picture
Figure 10. Global Gene Editing Market Size, (USD Million): 2022 VS 2028
Figure 11. Global Gene Editing Revenue and Forecast (2022-2028) & (USD Million)
Figure 12. Gene Editing Market Drivers
Figure 13. Gene Editing Market Restraints
Figure 14. Gene Editing Market Trends
Figure 15. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 16. Merck Recent Developments and Future Plans
Figure 17. Horizon Discovery Recent Developments and Future Plans
Figure 18. Sangamo BioSciences Recent Developments and Future Plans
Figure 19. Integrated DNA Technologies Recent Developments and Future Plans
Figure 20. Lonza Recent Developments and Future Plans
Figure 21. New England Biolabs Recent Developments and Future Plans
Figure 22. OriGene Technologies Recent Developments and Future Plans
Figure 23. Transposagen Biopharmaceuticals Recent Developments and Future Plans
Figure 24. Editas Medicine Recent Developments and Future Plans
Figure 25. CRISPR Therapeutics Recent Developments and Future Plans
Figure 26. RGen Solutions Recent Developments and Future Plans
Figure 27. Sigma-Aldrich Recent Developments and Future Plans
Figure 28. GeneCopoeia Recent Developments and Future Plans
Figure 29. Genscript Biotech Recent Developments and Future Plans
Figure 30. Global Gene Editing Revenue Market Share by Region (2022-2028)
Figure 31. Global Gene Editing Revenue Market Share by Region in 2028
Figure 32. North America Gene Editing Revenue (USD Million) and Growth Rate (2022-2028)
Figure 33. Europe Gene Editing Revenue (USD Million) and Growth Rate (2022-2028)
Figure 34. Asia-Pacific Gene Editing Revenue (USD Million) and Growth Rate (2022-2028)
Figure 35. South America Gene Editing Revenue (USD Million) and Growth Rate (2022-2028)
Figure 36. Middle East & Africa Gene Editing Revenue (USD Million) and Growth Rate (2022-2028)
Figure 37. Global Gene Editing Market Share Forecast by Type (2022-2028)
Figure 38. Global Gene Editing Market Share Forecast by Application (2022-2028)
Figure 39. Methodology
Figure 40. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
